Skip to content
10-Q

Quarterly Report

Lomond Therapeutics Holdings, Inc.

0001213900-25-076735

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 32.2M sh
Shares Diluted Q2 2025 · Jun 30, 2025 32.2M sh
Shares Diluted Q2 2025 · Jun 30, 2025 30.75M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 758.97K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 758.97K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$12.03M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 −$4.07M
Short Term Investments Q2 2025 · Jun 30, 2025 $27.57M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $7.65M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $28.42M
Stockholders Equity Q2 2025 · Jun 30, 2025 $29.98M
Stockholders Equity Q2 2025 · Mar 31, 2025 $36.6M
Stockholders Equity Q2 2025 · Dec 31, 2024 $23.76M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$5.29M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$5.65M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 −$5.52M
Current Liabilities Q2 2025 · Jun 30, 2025 $6.49M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.55M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.53M
Total Liabilities Q2 2025 · Dec 31, 2024 $5.5M
Current Assets Q2 2025 · Jun 30, 2025 $39.51M
Current Assets Q2 2025 · Dec 31, 2024 $29.25M
Total Assets Q2 2025 · Jun 30, 2025 $39.51M
Total Assets Q2 2025 · Dec 31, 2024 $29.25M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.23
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.44
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.09
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.44
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.09
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4.29
Sga Expense Q2 2025 · Jun 30, 2025 $1.04M
Sga Expense Q2 2025 · Jun 30, 2025 $2.4M
Sga Expense restated Q2 2025 · Jun 30, 2024 $99.21K
Sga Expense restated Q2 2025 · Jun 30, 2024 $243.08K
Rd Expense Q2 2025 · Jun 30, 2025 $6.62M
Rd Expense Q2 2025 · Jun 30, 2025 $11.78M
Rd Expense Q2 2025 · Jun 30, 2024 $3.01M
Rd Expense Q2 2025 · Jun 30, 2024 $3.02M
Net Income Q2 2025 · Jun 30, 2025 −$7.33M
Net Income Q2 2025 · Jun 30, 2025 −$13.53M
Net Income restated Q2 2025 · Jun 30, 2024 −$3.11M
Net Income restated Q2 2025 · Jun 30, 2024 −$3.26M
Operating Income Q2 2025 · Jun 30, 2025 −$7.66M
Operating Income Q2 2025 · Jun 30, 2025 −$14.18M
Operating Income restated Q2 2025 · Jun 30, 2024 −$3.11M
Operating Income restated Q2 2025 · Jun 30, 2024 −$3.26M